Clinical Trials Browser

Terminated × aflibercept × Clear all

NCT03712904 2025-09-24

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Phase 2 Terminated

3 enrolled 9 charts

Uveal Melanoma

NCT03710564 2023-01-30

MERLIN

Phase 3 Terminated

535 enrolled 14 charts

Macular Degeneration, Neurofibromatosis 2

NCT00794417 2020-12-10

A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

Phase 1/2 Terminated

60 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01669720 2020-02-17

C261

Phase 2 Terminated

10 enrolled 7 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02192541 2018-03-29

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Phase 1 Terminated

5 enrolled 15 charts

Neoplasms, Sarcoma

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00574275 2016-06-07

VANILLA

Phase 3 Terminated

546 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01955629 2016-04-18

AMOR

Phase 1/2 Terminated

4 enrolled 7 charts

Gastrointestinal

Colorectal Cancer Metastatic

NCT00509249 2015-01-08

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Phase 2 Terminated

18 enrolled 4 charts

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative